News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Nyrada.
RELATED STOCKHEAD STORIES
News
Closing Bell: The ASX is slightly higher, but not much cooler on Monday
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Bad week for benchmark; signals of a Sino solution, however, if Albo is able
Health & Biotech
Strokes cost the Australian economy billions, but these biotech players could change that
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: ASX falls flat after strong employment data muddies waters
News
ASX Small Caps and IPO Weekly Wrap: 30 hours of hot ASX action and we’re right back where we started
Health & Biotech
ASX Health Stocks: Silk Laser gives thumbs up to $180 million Wesfarmers bid, soars 18%
Health & Biotech
ASX Health Stocks: Anteris’ 3D heart valve shows consistent results; as Nyrada announces a new lead drug
News
Market Highlights: Wall Street enters bull territory; Bitcoin whale makes $38m after a 10-year hodl
Health & Biotech
ASX Health Stocks: MVP flies high after disclosing US ‘green whistle’ strategy, Imricor signs with prestigious Swiss hospital
Experts
MoneyTalks: Canary Capital’s Paul Hart reckons these are the biotech stocks to pop in the basket
News
Market Highlights: Wall Street gains, Aussie CPI ahead, and 5 ASX small caps to watch on Wednesday
News
Market highlights and 5 ASX small caps to watch on Wednesday
News
‘Ridiculous selling’: Small cap fund managers on buying the panic and where the bargains are
Experts
MoneyTalks: ASX biotechnology shares are deeply discounted – Paul Hart says ‘perfect time’ to buy
Health & Biotech
